Hippolyte Arcay
Papers
1
Total Citations
1
H-Index
1
About
Hippolyte Arcay is a pioneering researcher in the field of non-invasive brain stimulation, with a primary focus on treatment-resistant depression (TRD). His work bridges the gap between neuroimaging and personalized neuromodulation, aiming to optimize therapeutic outcomes for patients who do not respond to conventional treatments. Arcay’s most notable contribution is his 2025 proof-of-concept randomized trial, which demonstrated that individualizing repetitive transcranial magnetic stimulation (rTMS) based on patient-specific perfusion abnormalities can significantly enhance efficacy compared to standard rTMS and transcranial direct current stimulation (tDCS). This study, though recently published with 1 citation, represents a paradigm shift toward precision psychiatry, offering a novel framework for tailoring interventions to individual brain pathophysiology. By integrating advanced imaging biomarkers with targeted stimulation protocols, Arcay has laid the groundwork for more effective, patient-centered approaches in TRD management. His work underscores the potential of personalized neuromodulation to reduce the trial-and-error nature of current treatments, marking him as an emerging leader in translational neuroscience.
Research Focus
Key Achievements
Top Papers
- 1